- Peter Marks, the former director of the US FDA’s Center for Biologics Evaluation and Research who resigned in March under pressure from HHS Secretary Robert F. Kennedy Jr., is now at Eli Lilly (NYSE:LLY).
- Marks has joined the Indianapolis-based pharma
Former FDA CBER Director Peter Marks lands at Eli Lilly – report
